As the US Farm Bill undergoes potential amendments that could impact the use of cannabinoids in skincare, Galyna’s CEO sheds light on how these regulatory changes might affect the cosmetics industry and discusses the brand’s approach to innovation. The amendments could limit the sale of products containing cannabinoids not derived naturally from marijuana, which has sparked debate between marijuana companies and CBD product manufacturers. Insights from Galyna CEO on Farm Bill Amendment and Innovations highlight the evolving regulatory landscape and its implications for personal care products.
Courtesy of Galyna
Some marijuana companies are pushing for tighter controls, while CBD product companies advocate for keeping the federal definition of hemp intact. The House Agriculture Committee is particularly focused on restricting hemp products that contain any amount of THC, a psychoactive compound. Insights from Galyna CEO on Farm Bill Amendment and Innovations emphasize the importance of safety, labeling, and access to goods in shaping a well-regulated market.
Toby Ripsom, CEO and co-founder of Galyna, explains that while hemp regulations continue to develop, the cosmetic applications of cannabinoids are evolving. Galyna has developed a unique molecule that extends the lifespan and increases the absorption of cannabinoids into the skin, resulting in enhanced efficacy. According to Ripsom, cannabinoids have shown promising results for collagen production, wound healing, and acne treatment, offering advanced solutions beyond traditional formulations. Insights from Galyna CEO on Farm Bill Amendment and Innovations also reveal how Galyna’s scientific partnerships and commitment to innovation allow them to push boundaries in the CBD skincare space.
Courtesy of Galyna
Despite the challenges posed by changing regulations, Ripsom remains optimistic about the future of cannabinoids in personal care. He sees great potential for plant-based ingredients to enhance existing products and believes that new laws could help reduce stigma and increase research and investment in this area. As Galyna continues to expand, the brand is also preparing to meet the stringent standards required in European markets, ensuring that their products are held to the highest levels of quality and compliance.